These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10810759

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative study of different formulations of atenolol.
    Yasmeen R, Shoaib MH, Khalid H.
    Pak J Pharm Sci; 2005 Jan; 18(1):47-51. PubMed ID: 16431383
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Production and characterization of an atenolol-reticulated povodone tablet].
    Dobrecky J, Bregni C, Lamas MC, Cancelo G, Estévez SM.
    Boll Chim Farm; 2000 Jan; 139(5):209-12. PubMed ID: 11213439
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B, Chakkal SK, Ahuja N.
    AAPS PharmSciTech; 2006 Jan 13; 7(1):E3. PubMed ID: 16584161
    [Abstract] [Full Text] [Related]

  • 10. Development, validation and stability study of pediatric atenolol syrup.
    Foppa T, Murakami FS, Silva MA.
    Pharmazie; 2007 Jul 13; 62(7):519-21. PubMed ID: 17718193
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution.
    Johnson JR, Wang LH, Gordon MS, Chowhan ZT.
    J Pharm Sci; 1991 May 13; 80(5):469-71. PubMed ID: 1880728
    [Abstract] [Full Text] [Related]

  • 16. Compatibility of atenolol with excipients: LC-MS/TOF characterization of degradation/interaction products, and mechanisms of their formation.
    Kumar V, Shah RP, Malik S, Singh S.
    J Pharm Biomed Anal; 2009 May 01; 49(4):880-8. PubMed ID: 19217740
    [Abstract] [Full Text] [Related]

  • 17. Transdermal atenolol releasing system: an approach towards its development.
    Gupta SP, Jain SK.
    J Drug Target; 2006 Nov 01; 14(9):607-13. PubMed ID: 17090396
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Applications of excipients in the field of 3D printed pharmaceuticals.
    Tian P, Yang F, Yu LP, Lin MM, Lin W, Lin QF, Lv ZF, Huang SY, Chen YZ.
    Drug Dev Ind Pharm; 2019 Jun 01; 45(6):905-913. PubMed ID: 30744433
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.